Publications by authors named "Miranda Chapman"

Claim this Profile
P
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B.
Jerzy Windyga, Margarita Timofeeva, Oleksandra Stasyshyn, Vasily Mamonov, José Luis Lamas Castellanos, Miranda Chapman

Clin Appl Thromb Hemost· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.
Joan C Gill, Giancarlo Castaman, Jerzy Windyga, Peter Kouides, Margaret Ragni, Miranda Chapman

Blood· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes.
Peter L Turecek, Brigitt Abbühl, Srilatha D Tangada, Miranda Chapman, Herbert Gritsch

Expert Rev Clin Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.
Pier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, Edward Romond, Amy Shapiro, Miranda Chapman

Blood· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone formation with a biphasic calcium phosphate combined with fibrin sealant in maxillary sinus floor elevation for delayed dental implant.
Wilfried Wagner, Jörg Wiltfang, Hans Pistner, Murat Yildirim, Bettina Ploder, Miranda Chapman

Clin Oral Implants Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis